Stay In Treatment for Pediatric Weight Management (NCT04364282) | Clinical Trial Compass
CompletedNot Applicable
Stay In Treatment for Pediatric Weight Management
United States1,216 participantsStarted 2020-07-06
Plain-language summary
Attrition from pediatric weight management programs is unacceptably high, with dropout ranging from 27-73%. This project will utilize a model that predicts dropout from treatment, increasing its power and accuracy through a multi-site observational study. This will result in a powerful tool that will be used to decrease attrition from pediatric weight management, with the potential for widespread dissemination to improve treatment outcomes.
Who can participate
Age range
7 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Child is 7-18 years of age
* Participating child has been referred to one of the participating weight management programs, and the family (child-parent dyad) has chosen to participate in said program.
* Participating child is obese (BMI ≥95th percentile for age and sex).
* Participating child provides assent to participation in the research study.
* At least one parent/guardian consents to participate (and consent to child participation).
The parent should be the primary parent accompanying the child to treatment, and the child's primary residence must be with that parent.
\- Both members of the parent-child dyad must speak either English or Spanish.
Exclusion Criteria:
* Participating child cannot complete measures and study activities (non-verbal, significant developmental and behavioral challenges).
* Participating child has a chronic illness that impacts weight (i.e. cancer).
* Participating child with a genetic condition (i.e. Prader-Willi) that is associated with excessive weight.
* One member of the parent-child dyad refuses to participate in the study or does not wish to complete 6 months of treatment.
* One member of the parent-child dyad is unable to participate in 6 month follow-up data collection.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.